Stock price graph

Stock Quote


Price: 4.12
Change: 0.00
Day High: N/A
Day Low: N/A
Volume: N/A

4:00 PM ET on Dec 8, 2016

Delayed at least 20 minutes.
Provided by eSignal.

Investors & Media


We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc.'s financial performance into perspective.

Recent Releases

Dec 1, 2016

Cyclacel's Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia

Dec 1, 2016

EORTC-NCI-AACR 2016. Abstract 355: Therapeutic potential of novel PLK1 inhibitor, CYC140, in esophageal cancer and acute leukemia

View All >

Events & Presentations

Nov 14, 2016 at 4:30 PM ET

Third Quarter 2016 Financial Results

Aug 10, 2016 at 4:30 PM ET

Second Quarter 2016 Financial Results

View All >

Annual Reports


Annual Report

View All >

Investors & Media